RVL Pharmaceuticals plc·4

Jan 26, 4:30 PM ET

Schaub James 4

4 · RVL Pharmaceuticals plc · Filed Jan 26, 2022

Insider Transaction Report

Form 4
Period: 2022-01-24
Schaub James
EVP and COO
Transactions
  • Tax Payment

    Ordinary Shares

    2022-01-24$1.13/sh9,607$10,856396,293 total

Documents

1 file
  • 4
    tm223506-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT